Literature DB >> 15351776

Inhibitory effect of a bitter melon extract on the P-glycoprotein activity in intestinal Caco-2 cells.

Tomoko Konishi1, Hideo Satsu, Yasuo Hatsugai, Koichi Aizawa, Takahiro Inakuma, Shinji Nagata, Sho-Hei Sakuda, Hiromichi Nagasawa, Makoto Shimizu.   

Abstract

Extracts of bitter melon, soybean, dokudami and welsh onion by 40% methanol increased the accumulation of rhodamine-123 by Caco-2 cells, suggesting that these extracts inhibited P-glycoprotein (P-gp). The extract of bitter melon was separated in a tC18 cartridge column and the eluate from 80% acetonitrile most markedly increased the [(3)H]-daunomycin accumulation by Caco-2 cells. The inhibitory compounds in the bitter melon fraction were isolated by HPLC with Pegasil C4 and Pegasil ODS columns. The HPLC fraction having the highest activity was analyzed by (1)H-NMR and FAB-MS, and the active compound was identified as 1-monopalmitin. The inhibitory activities of 1-monopalmitin and its related compounds suggested that the inhibition of P-gp activity was not dependent on the degree of unsaturation of fatty acid in the monoglyceride, but on the chain length. It was also suggested that the monoglyceride structure played an important role in the inhibition of P-gp activity. Monoglycerides could therefore alter the pharmacokinetics of drugs by inhibiting the P-gp-mediated efflux.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15351776      PMCID: PMC1575343          DOI: 10.1038/sj.bjp.0705804

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  31 in total

1.  Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein.

Authors:  R B Kim; C Wandel; B Leake; M Cvetkovic; M F Fromm; P J Dempsey; M M Roden; F Belas; A K Chaudhary; D M Roden; A J Wood; G R Wilkinson
Journal:  Pharm Res       Date:  1999-03       Impact factor: 4.200

2.  Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit juice components in caco-2 cells.

Authors:  H Takanaga; A Ohnishi; H Matsuo; Y Sawada
Journal:  Biol Pharm Bull       Date:  1998-10       Impact factor: 2.233

3.  Treatment with extracts of Momordica charantia and Eugenia jambolana prevents hyperglycemia and hyperinsulinemia in fructose fed rats.

Authors:  V Vikrant; J K Grover; N Tandon; S S Rathi; N Gupta
Journal:  J Ethnopharmacol       Date:  2001-07       Impact factor: 4.360

4.  Inhibition of P-glycoprotein activity and reversal of multidrug resistance in vitro by rosemary extract.

Authors:  C A Plouzek; H P Ciolino; R Clarke; G C Yeh
Journal:  Eur J Cancer       Date:  1999-10       Impact factor: 9.162

Review 5.  Intestinal absorption of triglyceride and cholesterol. Dietary and pharmacological inhibition to reduce cardiovascular risk.

Authors:  E Ros
Journal:  Atherosclerosis       Date:  2000-08       Impact factor: 5.162

6.  Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. Kinetics of vinblastine secretion and interaction with modulators.

Authors:  J Hunter; M A Jepson; T Tsuruo; N L Simmons; B H Hirst
Journal:  J Biol Chem       Date:  1993-07-15       Impact factor: 5.157

7.  ATP and GTP as alternative energy sources for vinblastine transport by P-170 in KB-V1 plasma membrane vesicles.

Authors:  I H Lelong; R Padmanabhan; E Lovelace; I Pastan; M M Gottesman
Journal:  FEBS Lett       Date:  1992-06-15       Impact factor: 4.124

8.  Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1).

Authors:  Y Tanigawara; N Okamura; M Hirai; M Yasuhara; K Ueda; N Kioka; T Komano; R Hori
Journal:  J Pharmacol Exp Ther       Date:  1992-11       Impact factor: 4.030

9.  A new functional role for P-glycoprotein: efflux pump for benzo(alpha)pyrene in human breast cancer MCF-7 cells.

Authors:  G C Yeh; J Lopaczynska; C M Poore; J M Phang
Journal:  Cancer Res       Date:  1992-12-01       Impact factor: 12.701

10.  The role of surfactants in the reversal of active transport mediated by multidrug resistance proteins.

Authors:  Katrijn Bogman; Françoise Erne-Brand; Jochem Alsenz; Jürgen Drewe
Journal:  J Pharm Sci       Date:  2003-06       Impact factor: 3.534

View more
  17 in total

Review 1.  Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption.

Authors:  Joseph M Custodio; Chi-Yuan Wu; Leslie Z Benet
Journal:  Adv Drug Deliv Rev       Date:  2007-11-28       Impact factor: 15.470

2.  Bitter melon extracts enhance the activity of chemotherapeutic agents through the modulation of multiple drug resistance.

Authors:  Deep Kwatra; Anand Venugopal; David Standing; Sivapriya Ponnurangam; Animesh Dhar; Ashim Mitra; Shrikant Anant
Journal:  J Pharm Sci       Date:  2013-10-15       Impact factor: 3.534

Review 3.  Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy.

Authors:  Komal Raina; Dileep Kumar; Rajesh Agarwal
Journal:  Semin Cancer Biol       Date:  2016-07-21       Impact factor: 15.707

4.  Bitter melon juice activates cellular energy sensor AMP-activated protein kinase causing apoptotic death of human pancreatic carcinoma cells.

Authors:  Manjinder Kaur; Gagan Deep; Anil K Jain; Komal Raina; Chapla Agarwal; Michael F Wempe; Rajesh Agarwal
Journal:  Carcinogenesis       Date:  2013-03-08       Impact factor: 4.944

5.  Food dyes as P-glycoprotein modulators.

Authors:  Jack W Staples; Jessica M Stine; Eero Mäki-Lohiluoma; Emily Steed; Kathleen M George; Charles M Thompson; Erica L Woodahl
Journal:  Food Chem Toxicol       Date:  2020-10-01       Impact factor: 6.023

6.  Andrographis paniculata Extract and Andrographolide Modulate the Hepatic Drug Metabolism System and Plasma Tolbutamide Concentrations in Rats.

Authors:  Haw-Wen Chen; Chin-Shiu Huang; Pei-Fen Liu; Chien-Chun Li; Chiung-Tong Chen; Cheng-Tzu Liu; Jia-Rong Chiang; Hsien-Tsung Yao; Chong-Kuei Lii
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-12       Impact factor: 2.629

7.  Evaluation of the potential effect of Allium sativum, Momordica charantia, Eugenia jambolana, Ocimum sanctum, and Psidium guajava on intestinal p-glycoprotein in rats.

Authors:  Devendra Kumar; Neerja Trivedi; Rakesh K Dixit
Journal:  J Intercult Ethnopharmacol       Date:  2016-09-21

8.  Pharmacogenomics Implications of Using Herbal Medicinal Plants on African Populations in Health Transition.

Authors:  Nicholas E Thomford; Kevin Dzobo; Denis Chopera; Ambroise Wonkam; Michelle Skelton; Dee Blackhurst; Shadreck Chirikure; Collet Dandara
Journal:  Pharmaceuticals (Basel)       Date:  2015-09-21

9.  A novel perspective and approach to intestinal octreotide absorption: sinomenine-mediated reversible tight junction opening and its molecular mechanism.

Authors:  Yuling Li; Zhijun Duan; Yan Tian; Zhen Liu; Qiuming Wang
Journal:  Int J Mol Sci       Date:  2013-06-20       Impact factor: 5.923

10.  Cepharanthine hydrochloride reverses the mdr1 (P-glycoprotein)-mediated esophageal squamous cell carcinoma cell cisplatin resistance through JNK and p53 signals.

Authors:  Pengjun Zhou; Rong Zhang; Ying Wang; Dandan Xu; Li Zhang; Jinhong Qin; Guifeng Su; Yue Feng; Hongce Chen; Siyuan You; Wen Rui; Huizhong Liu; Suhong Chen; Hongyuan Chen; Yifei Wang
Journal:  Oncotarget       Date:  2017-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.